Skip to main content
Tinavi Medical Technologies Co.,Ltd. logo

Tinavi Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688277 ISIN · CNE100004256 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 760 across all filing types
Latest filing 2026-01-12 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688277

About Tinavi Medical Technologies Co.,Ltd.

https://www.tinavi.com/

Tinavi Medical Technologies Co.,Ltd. specializes in the design, development, and commercialization of orthopedic surgical robotic systems. Its primary offering, the TiRobot system, provides a multi-functional platform for spine and trauma surgeries, supporting procedures such as pedicle screw fixation and pelvic fracture reduction. The technology incorporates high-definition 3D imaging, precise mechanical arms, and advanced navigation software to facilitate minimally invasive operations with sub-millimeter accuracy. By integrating preoperative planning with real-time intraoperative guidance, the system aims to enhance surgical precision, reduce recovery times, and minimize radiation exposure for clinical teams. The company focuses on delivering intelligent robotic solutions to hospitals and specialized surgical centers to improve the consistency and safety of complex orthopedic interventions.

Recent filings

Filing Released Lang Actions
中信建投证券股份有限公司关于北京天智航医疗科技股份有限公司部分募投项目延期的核查意见
Regulatory Filings Classification · 85% confidence The document is a sponsor’s due-diligence opinion (核查意见) by the company’s underwriter regarding the delay of certain projects financed by a prior share issuance. It does not present financial statements, nor is it an earnings release, proxy, or investor presentation. It is a regulatory‐compliance document filed under listing rules, with no specific category such as capital structure change or dividends. This fits the “Regulatory Filings” (RNS) fallback for miscellaneous compliance materials.
2026-01-12 Chinese
关于持股5%以上股东权益变动触及1%刻度的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a change in shareholding by shareholders holding more than 5% of the company's shares. It details the decrease in shareholding percentages, the methods of share reduction (block trades and centralized bidding), and confirms that the change does not trigger mandatory tender offers or control changes. The document references relevant securities laws and disclosure requirements. It is a notification of a major shareholding change rather than a financial report, management discussion, or other types of filings. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming this classification.
2026-01-08 Chinese
2025年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 third extraordinary general meeting of shareholders of Beijing Tianzhihang Medical Technology Co., Ltd. It includes information about the meeting date, location, attendance, voting results on various proposals, and legal witness statements confirming the validity of the meeting and resolutions. The content focuses on the voting results and decisions made at the shareholders' meeting rather than the meeting materials or presentations themselves. The document length is 2664 characters, which is relatively short but contains substantive voting results data. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. Therefore, the correct classification is DVA with high confidence.
2025-12-30 Chinese
北京德恒律师事务所关于北京天智航医疗科技股份有限公司2025年第三次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion from a law firm regarding the convening, conduct, and voting at the company’s 2025 third Extraordinary General Meeting. It includes detailed voting results for each resolution (shares for, against, abstained) and provides a formal declaration that the results are valid. This falls squarely under “Declaration of Voting Results & Voting Rights Announcements (DVA)” rather than a broader legal proceeding or annual/interim report.
2025-12-30 Chinese
关于归还临时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Beijing Tianzhihang Medical Technology Co., Ltd. regarding the repayment of temporarily supplemented working capital from raised funds. It details the amount repaid, the timeline, and references a previous announcement about the use of idle raised funds for working capital. The document is short (961 characters) and serves as a formal notice about the status of capital usage and repayment rather than a detailed financial report or analysis. It does not contain financial statements or comprehensive financial data. This fits the description of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2025-12-23 Chinese
2025年第三次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "2025 年第三次临时股东大会会议资料" which translates to "2025 Third Extraordinary General Meeting (EGM) Meeting Materials". It contains detailed meeting instructions, agenda, proposals for shareholder approval, and governance-related amendments such as changes to the supervisory board, capital changes, and amendments to the company charter. The content is clearly materials prepared for a shareholders' meeting, including proposals and governance documents to be discussed and voted on. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document is not a report of voting results, nor is it a proxy solicitation or a regulatory filing. It is not an annual or interim report, nor an earnings release. The length and detail confirm it is the meeting materials themselves, not just an announcement of a meeting or report publication. Therefore, the correct classification is AGM Information (AGM-R).
2025-12-22 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.